Archford Capital Strategies, LLC
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1606609
SWANSEA, IL
Position in REGN
as of Jun 30, 2026
· filed Jul 17, 2026
Position Value
$650,352
-$151,648 QoQ
Shares Held
1,043
+0.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#740
of 1,322 holders
Holding Since
Mar 2020
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Archford Capital Strategies, LLC holds $1,967,528 across 3 Biotechnology names. REGN ranks #2 (33.1% of the industry book) .
All Filings in REGN
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $650,352 | 1,043 | Shares | Sole | 2026-07-17 | |
| 2026-03-31 | $802,000 | 1,038 | Shares | Sole | 2026-04-15 | |
| 2021-09-30 | $587,629 | 971 | Shares | Sole | 2021-10-14 | |
| 2021-06-30 | $533,405 | 955 | Shares | Sole | 2021-07-23 | |
| 2021-03-31 | $422,040 | 892 | Shares | Sole | 2021-04-26 | |
| 2020-12-31 | $302,426 | 626 | Shares | Sole | 2021-01-19 | |
| 2020-09-30 | $241,824 | 432 | Shares | Sole | 2020-10-19 | |
| 2020-06-30 | $346,125 | 555 | Shares | Sole | 2020-07-24 | |
| 2020-03-31 | $235,844 | 483 | Shares | Sole | 2020-04-29 | |
| No filing history on record for this holder in this stock. | ||||||